Eric Weisblum - 18 Nov 2025 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Weisblum
Issuer symbol: SILO
Transactions as of: 18 Nov 2025
Net transactions value: +$4,847
Form type: 4
Filing time: 20 Nov 2025, 16:00:32 UTC
Previous filing: 28 May 2025
Next filing: 21 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Weisblum Eric	Chief Executive Officer, Director	C/O SILO PHARMA, INC., 677 N. WASHINGTON BOULEVARD, SARASOTA	/s/ Eric Weisblum	20 Nov 2025	0001569077

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$3,025	+7,500	+3.8%	$0.4033	205,432	18 Nov 2025	Direct	F1
transaction	SILO	Common Stock	Purchase	$1,822	+4,500	+2.2%	$0.4050	209,932	19 Nov 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.